Syros Pharmaceuticals Inc (SYRS)
5.435
-0.04
(-0.82%)
USD |
NASDAQ |
May 17, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Free Cash Flow: -103.90M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -103.90M |
| December 31, 2023 | -109.98M |
| September 30, 2023 | -123.14M |
| June 30, 2023 | -127.39M |
| March 31, 2023 | -131.30M |
| December 31, 2022 | -124.31M |
| September 30, 2022 | -115.76M |
| June 30, 2022 | -108.08M |
| March 31, 2022 | -108.68M |
| December 31, 2021 | -100.78M |
| September 30, 2021 | -107.52M |
| June 30, 2021 | -94.86M |
| March 31, 2021 | -81.40M |
| December 31, 2020 | -60.70M |
| September 30, 2020 | -49.51M |
| June 30, 2020 | -47.52M |
| March 31, 2020 | -53.52M |
| Date | Value |
|---|---|
| December 31, 2019 | -72.89M |
| September 30, 2019 | -68.14M |
| June 30, 2019 | -65.39M |
| March 31, 2019 | -60.06M |
| December 31, 2018 | -41.70M |
| September 30, 2018 | -38.33M |
| June 30, 2018 | -36.86M |
| March 31, 2018 | -34.89M |
| December 31, 2017 | -45.55M |
| September 30, 2017 | -44.83M |
| June 30, 2017 | -44.60M |
| March 31, 2017 | -43.93M |
| December 31, 2016 | -42.86M |
| September 30, 2016 | -41.44M |
| June 30, 2016 | -38.27M |
| March 31, 2016 | -32.97M |
| December 31, 2015 | -24.21M |
Free Cash Flow Range, Past 5 Years
-131.30M
Minimum
Mar 2023
-47.52M
Maximum
Jun 2020
-92.74M
Average
-102.34M
Median
Free Cash Flow Benchmarks
| PAVmed Inc | -49.04M |
| Moderna Inc | -3.672B |
| Altimmune Inc | -72.76M |
| iBio Inc | -18.89M |
| Lixte Biotechnology Holdings Inc | -3.811M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.10M |
| Cash from Investing (Quarterly) | -24.64M |
| Cash from Financing (Quarterly) | -0.265M |
| Free Cash Flow Per Share (Quarterly) | -0.7978 |
| Free Cash Flow Yield | -61.28% |